Literature DB >> 9140045

Distribution and developmentally regulated expression of murine polycystin.

L Geng1, Y Segal, A Pavlova, E J Barros, C Löhning, W Lu, S K Nigam, A M Frischauf, S T Reeders, J Zhou.   

Abstract

PKD1, the gene that is mutated in approximately 85% of autosomal dominant polycystic kidney disease (ADPKD) cases in humans, has recently been identified (Eur. PKD Consortium. Cell 77: 881-894, 1994; also, erratum in Cell 78: 1994). The longest open-reading frame of PKD1 encodes polycystin, a novel approximately 460-kDa protein that contains a series of NH2-terminal adhesive domains (J. Hughes, C. J. Ward, B. Peral, R. Aspinwall, K. Clark, J. San Millan, V. Gamble, and P. C. Harris. Nat. Genet. 10: 151-160, 1995; and Int. PKD Consortium. Cell 81: 289-298, 1995) and several putative transmembrane segments. To extend studies of polycystin to an experimentally accessible animal, we have isolated a cDNA clone encoding the 3' end of Pkd1, the mouse homologue of PKD1, and raised a specific antibody to recombinant murine polycystin. This antibody was used to determine the subcellular localization and tissue distribution of the protein by Western analysis and immunocytochemistry. In the mouse, polycystin is an approximately 400-kDa molecule that is predominantly found in membrane fractions of tissue and cell extracts. It is expressed in many tissues including kidney, liver, pancreas, heart, intestine, lung, and brain. Renal expression, which is confined to tubular epithelia, is highest in late fetal and early neonatal life and drops 20-fold by the third postnatal week, maintaining this level into adulthood. Thus the temporal profile of polycystin expression coincides with kidney tubule differentiation and maturation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140045     DOI: 10.1152/ajprenal.1997.272.4.F451

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  36 in total

Review 1.  Polycystic kidney disease: In danger of being X-rated?

Authors:  J J Grantham; J P Calvet
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Altered trafficking and stability of polycystins underlie polycystic kidney disease.

Authors:  Yiqiang Cai; Sorin V Fedeles; Ke Dong; Georgia Anyatonwu; Tamehito Onoe; Michihiro Mitobe; Jian-Dong Gao; Dayne Okuhara; Xin Tian; Anna-Rachel Gallagher; Zhangui Tang; Xiaoli Xie; Maria D Lalioti; Ann-Hwee Lee; Barbara E Ehrlich; Stefan Somlo
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

Review 3.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

Review 4.  ADPKD: molecular characterization and quest for treatment.

Authors:  Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

Review 5.  Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential.

Authors:  Robert J Kolb; Surya M Nauli
Journal:  Front Biosci       Date:  2008-05-01

6.  Novel functional complexity of polycystin-1 by GPS cleavage in vivo: role in polycystic kidney disease.

Authors:  Almira Kurbegovic; Hyunho Kim; Hangxue Xu; Shengqiang Yu; Julie Cruanès; Robin L Maser; Alessandra Boletta; Marie Trudel; Feng Qian
Journal:  Mol Cell Biol       Date:  2014-06-23       Impact factor: 4.272

Review 7.  The primary cilium calcium channels and their role in flow sensing.

Authors:  Amanda Patel
Journal:  Pflugers Arch       Date:  2014-04-26       Impact factor: 3.657

Review 8.  Rationale for early treatment of polycystic kidney disease.

Authors:  Jared J Grantham
Journal:  Pediatr Nephrol       Date:  2014-07-15       Impact factor: 3.714

Review 9.  A cut above (and below): Protein cleavage in the regulation of polycystin trafficking and signaling.

Authors:  Valeria Padovano; Kavita Mistry; David Merrick; Nikolay Gresko; Michael J Caplan
Journal:  Cell Signal       Date:  2020-04-10       Impact factor: 4.315

10.  Bardet-Biedl syndrome proteins 1 and 3 regulate the ciliary trafficking of polycystic kidney disease 1 protein.

Authors:  Xuefeng Su; Kaitlin Driscoll; Gang Yao; Anas Raed; Maoqing Wu; Philip L Beales; Jing Zhou
Journal:  Hum Mol Genet       Date:  2014-06-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.